Salta al contenuto principale

Central core disease

Central core disease is a disorder that affects muscles used for movement (skeletal muscles). This condition causes muscle weakness that ranges from barely noticeable to very severe. The severity of muscle weakness may differ even among affected members of the same family.

Descrizione

Central core disease is a disorder that affects muscles used for movement (skeletal muscles). This condition causes muscle weakness that ranges from barely noticeable to very severe. The severity of muscle weakness may differ even among affected members of the same family.

Most people with central core disease experience persistent, mild muscle weakness that does not worsen with time. This weakness affects the muscles near the center of the body (proximal muscles), particularly muscles in the shoulders, upper legs, and hips. Muscle weakness in affected infants can delay the development of motor skills such as sitting, standing, and walking; most people with this condition are able to walk independently. Affected individuals may experience muscle pain (myalgia) or extreme fatigue in response to physical activity (exercise intolerance). Central core disease is also associated with eyes that do not look in the same direction (strabismus), a rounded upper back that also curves to the side (kyphoscoliosis), foot deformities, hip dislocation, and joint deformities called contractures that restrict the movement of certain joints. In severe cases, affected infants experience weakness in the muscles of the face, profound low muscle tone (hypotonia), and serious or life-threatening breathing problems.

Many people with central core disease also have an increased risk of developing a severe reaction to certain drugs used during surgery and other invasive procedures. This reaction is called malignant hyperthermia. Malignant hyperthermia occurs in response to some anesthetic gases, which are used to block the sensation of pain, either given alone or in combination with a muscle relaxant that is used to temporarily paralyze a person during a surgical procedure. If given these drugs, people at risk of malignant hyperthermia may experience a rapid increase in heart rate (tachycardia) and body temperature (hyperthermia), abnormally fast breathing (tachypnea), muscle rigidity, breakdown of muscle fibers (rhabdomyolysis), and increased acid levels in the blood and other tissues (acidosis). The complications of malignant hyperthermia can be life-threatening unless they are treated promptly.

Central core disease gets its name from disorganized areas called central cores, which are typically found in the center of skeletal muscle cells, but can be at the edges or span the length of the cell, in many affected individuals. These abnormal regions can only been seen when muscle tissue is viewed under a microscope. These central cores are often present in cells with few or no mitochondria, which produce energy within cells. Although the presence of central cores can help doctors diagnose central core disease, it is unclear how they are related to muscle weakness and the other features of this condition.

Modelli di ereditarietà

The source lists the following possible inheritance patterns: Autosomal recessive; Autosomal dominant. More than one pattern can apply in different cases.

Altri nomi

CCD

CCO

Central core myopathy

Myopathy, central core

Shy's disease

Shy-Magee syndrome

Related patient information and medicines

Malattia celiaca

Patient information leaflet

Malattia celiaca

Coeliac disease (also spelled celiac disease) mainly affects the part of the gut called the small intestine. It can occur at any age. Some people with coeliac disease are also sensitive to oats. People with coeliac disease make antibodies against gluten. They may also be the cause of some of the problems that a person with coeliac disease can have.

Malattia di Parkinson

Patient information leaflet

Malattia di Parkinson

The main symptoms of Parkinson's disease are usually stiffness, shaking (tremor), and slowness of movement. What is Parkinson's disease. Malattia di Parkinson è a progressive neurological degeneration of certain cells (called dopaminergic cells) within a specific part of the brain (substantia nigra). The deficiency of dopamine leads to a movement.

Malattie cardiovascolari

Patient information leaflet

Malattie cardiovascolari

Cardiovascular diseases (CVD) is a general term to describe diseases of the heart or blood vessels. The cause of most malattie cardiovascolari is a build-up of ateroma - a fatty deposit within the inside lining of arteries. The blood flow to the heart muscle may also be restricted by a blood clot in an artery taking blood to the heart muscle.

Malattie cardiache

Patient information leaflet

Malattie cardiache

The heart is a muscle pump located in the chest, which pumps blood around the body. It keeps pumping from a few weeks after conception until we die. There are a number of different conditions that can affect how the heart works. Heart disease symptoms These include: Chest pain (the most well-known symptom of heart disease). Central crushing chest.

Valutazione del rischio per la salute cardiovascolare

Patient information leaflet

Valutazione del rischio per la salute cardiovascolare

A cardiovascular health risk assessment provides an accurate estimate of your risk of developing cardiovascular disease (eg, angina, heart attack, stroke or peripheral arterial disease) over the following 10 years, and provides an opportunity for you to make any changes that will reduce this risk. A cardiovascular risk assessment is an assessment.

Malattia di Huntington

Patient information leaflet

Malattia di Huntington

Huntington's disease is a genetically inherited condition that causes parts of the brain and nervous system to stop working properly over time. It is a slowly progressive condition that interferes with the movements of your body, thinking and judgement, and can lead to a change in your behaviour. The symptoms occur because of damage and death of.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 27 Mar 2023 | Ultima versione
  • 1 Oct 2007 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.
verifica idoneità al vaccino antinfluenzale

Chiedi, condividi, connettiti.

Esplora le discussioni, fai domande e condividi esperienze su centinaia di argomenti di salute.

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.